Tuesday, March 8, 2011

Bad Medicine - GSK ($750 million)

Continuing my series on recent False Claims Act cases, the most recent big one was the case involving GSK, which agreed to plead guilty to charges relating to the manufacture and distribution of certain adulterated drugs made at GSK’s now-closed Cidra, Puerto Rico, manufacturing facility.  The resolution included a criminal fine and forfeiture totaling $150 million and a civil settlement under the False Claims Act and related state claims for $600 million.  Click here for the DoJ press release. 
Here is the 60 minutes story about GSK whistleblower Cheryl Eckard.



No comments:

Post a Comment